Properties
Description
BJE6-106 blocks the function of Smad proteins in the TGF-β signaling pathway. It targets PKCα, and PKCδ.
Molecular Formula
C26H23NO2
Targets
PKCα: 50 μM; PKCδ: 0.05 μM
Applications
BJE6-106 can be used to impede tumor growth and metastasis, offering a potential therapeutic option for breast cancer patients who are refractory to standard treatments.